Effects of ipragliflozin, a selective sodium-glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials (Q90856720)
Jump to navigation
Jump to search
scientific article published on 09 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of ipragliflozin, a selective sodium-glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials |
scientific article published on 09 September 2016 |
Statements
Effects of ipragliflozin, a selective sodium-glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials (English)
Atsunori Kashiwagi
Satoshi Yoshida
Kosei Kawamuki
Ichiro Nakamura
Kenichi Kazuta
Eiji Ueyama
Hideyuki Takahashi
Noriko Akiyama
Yoshinori Kondo
Toshio Ogihara
9 September 2016